Track the Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) share price and the full management transaction log of the company, a listed issuer based in Canada. Shares trade on the CA market, under the authority of SEDI. Market capitalisation: €80.4m. The latest transaction was reported on 7 August 2026 (50 - Grant of options). Among the most active insiders: Blair, Tony. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Zomedica Corp. is a biotechnology company focused on developing diagnostic and therapeutic products for companion animals. It aims to improve animal health through innovative solutions.